CGEM Stock Analysis: Buy, Sell, or Hold?
CGEM - Cullinan Therapeutics, Inc. Common Stock
$16.15
-0.18 (-1.10%)
▼
5d:
+9.71%
30d:
+8.03%
90d:
+38.15%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When CGEM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CGEM this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CGEM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CGEM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CGEM is currently trading at $16.15, which is considered extended relative to its 30-day fair value range of $13.49 to $15.21.
Technical Outlook: Technically, CGEM is in a strong uptrend. The price is approaching resistance at $16.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CGEM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $31.55 (+95.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CGEM is in a strong uptrend. The price is approaching resistance at $16.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CGEM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $31.55 (+95.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.49 -
$15.21
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+6.2% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 95.3% below Wall St target ($31.55)
Trading Range Analysis
30-Day Trading Range
$13.49 -
$15.21
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$12.89
Resistance Level
$16.54
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.78
Wall Street Target
$31.55
(+95.3%)
Share & Embed Analysis
Last updated: May 14, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
Data refreshes hourly during market hours. Next update: 6:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGEM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jennifer Michaelson
SELL
8000 shares
2026-03-05
Jennifer Michaelson
SELL
1780 shares
2026-02-25
Jacquelyn L Sumer
SELL
3601 shares
2026-02-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 66 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$104 | 60 BUY |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 54 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$181 | 59 HOLD |
